Stock listing

TPEx:4183 EPS Bio Technology Corp. (福永生技) 股價

Follow EPS Bio Technology Corp. into a list and get an email when it puts out news.

Share price · TPEX:4183

$13.25 TWD -1.25 (-8.6%)

Close on Nov 20, 2026

Past year -24.3% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$13.20 – $13.80 TWDNov 20, 2026
Volume
28,001 sharesNov 20, 2026
Market cap
$315.4M TWDAt the close on Nov 20, 2026 · price × 23.80M shares outstanding
52-week range
$11.60 – $17.55 TWDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$85,087 TWDMedian day 2,000 shares · 20 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
EPS Bio Technology Corp. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TPEX:4183 · TWD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$13.25-1.25-8.6%$13.60$13.80$13.2028,001
$14.500.000.0%$14.40$14.50$14.406,000
$14.50+0.10+0.7%$13.75$14.50$13.7524,000
$14.400.000.0%$14.25$14.40$14.257,000
$14.400.000.0%$13.40$14.50$13.4011,000
$14.40-0.10-0.7%$14.40$14.40$14.407,000
$14.500.000.0%$14.45$14.50$14.456,000
$14.50+0.10+0.7%$14.50$14.50$14.4014,000
$14.400.000.0%$14.40$14.40$14.400
$14.400.000.0%$14.40$14.40$14.400
$14.400.000.0%$14.40$14.40$14.409,114
$14.400.000.0%$14.35$14.40$14.3512,114
$14.400.000.0%$14.40$14.40$14.400
$14.400.000.0%$14.40$14.40$14.402,000
$14.40+0.35+2.5%$14.40$14.40$14.401,000
$14.05-0.45-3.1%$14.50$14.55$14.057,000
$14.50+0.90+6.6%$13.60$14.50$13.6013,000
$13.60-0.70-4.9%$13.20$13.60$13.1511,000
$14.300.000.0%$14.30$14.30$14.300
$14.30+0.10+0.7%$14.85$15.35$14.2520,254
$14.200.000.0%$14.20$14.20$14.200
$14.200.000.0%$14.20$14.20$14.200
$14.200.000.0%$14.20$14.20$14.200
$14.200.000.0%$14.20$14.20$14.201,010
$14.20-0.40-2.7%$14.20$14.20$14.201,000
$14.600.000.0%$14.60$14.60$14.600
$14.60-0.15-1.0%$13.75$14.60$13.753,001
$14.750.000.0%$14.75$14.75$14.750
$14.750.000.0%$14.75$14.75$14.750
$14.750.000.0%$14.75$14.75$14.750
$14.750.000.0%$14.75$14.75$14.750
$14.75+0.40+2.8%$14.75$14.75$14.751,000
$14.35-0.10-0.7%$14.35$14.35$14.353,000
$14.45+0.90+6.6%$14.00$14.45$14.007,041
$13.55-0.40-2.9%$13.90$13.95$13.553,000
$13.95+0.65+4.9%$13.30$13.95$13.307,000
$13.30-0.95-6.7%$13.30$13.30$13.3014,000
$14.25+0.60+4.4%$13.85$14.25$13.8516,000
$13.65-0.70-4.9%$14.35$14.35$13.6521,004
$14.35+1.30+10.0%$13.50$14.35$13.5061,000
$13.050.000.0%$13.00$13.05$13.008,000
$13.050.000.0%$13.30$13.30$13.052,000
$13.05-0.15-1.1%$13.00$13.05$13.002,000
$13.20-0.30-2.2%$13.20$13.20$13.201,000
$13.500.000.0%$13.50$13.50$13.203,000
$13.50-0.70-4.9%$13.35$13.50$13.353,000
$14.200.000.0%$14.20$14.20$14.200
$14.200.000.0%$14.20$14.20$14.200
$14.200.000.0%$14.20$14.20$14.200
$14.200.000.0%$14.20$14.20$14.200
$14.20+0.20+1.4%$14.20$14.20$14.202,005
$14.000.000.0%$14.00$14.00$14.000
$14.000.000.0%$14.00$14.00$14.001,000
$14.000.000.0%$14.00$14.00$14.001,000
$14.000.000.0%$14.00$14.00$14.000
$14.000.000.0%$14.00$14.00$14.002,000
$14.00+0.30+2.2%$13.50$14.00$13.5019,000
$13.70-0.50-3.5%$13.70$13.70$13.701,039
$14.200.000.0%$14.20$14.20$14.200
$14.20+0.20+1.4%$13.55$14.20$13.552,005
$14.000.000.0%$14.00$14.00$14.000
$14.00-0.10-0.7%$14.50$14.60$14.0011,000

Splits

1 split · TPEX:4183 · every price before a split is adjusted for it

DayRatioWhat
26-for-25Split
Ticker
TPEx:4183
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
TPEx
Currency
TWD

Latest news

All EPS Bio Technology Corp. news

EPS Bio Technology Corp. on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
5 in all · newest Aug 4, 2022 · oldest 2022

Valuation

EV/sales 0.4× against a median of 8.6×: 3rd lowest of 9 Medical devices & supplies companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$190.2M TWD
P/E
Loss
EV/sales
0.4×
EV/EBITDA
21.4×
Price/book
1.2×
Gross margin
17.4%
Operating margin
−1.3%
Net margin
−1.6%
Debt to equity
0.0×
Beta
No index for this market yet

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
EPS Bio Technology Corp. · TPEX:4183US$9.57MUS$5.77Mn/a0.4×21.4×1.2×−1.6%0.0×n/a
Femasys Inc. · NASDAQ:FEMYUS$10.73M−US$8.31Mn/a−4.2×n/a0.4×−614.7%0.2×1.60
ADM Tronics Unlimited, Inc. · OTC:ADMTUS$9.97MUS$9.77Mn/a3.0×n/a13.4×−4.3%0.0×-1.45
United Health Products, Inc. · OTC:UEECUS$9.69MUS$9.69Mn/an/an/an/an/an/a-0.09
Guided Therapeutics, Inc. · OTC:GTHPUS$9.65MUS$9.68Mn/a14.2×n/an/a−445.9%n/a-0.75
Nestmedic SA · NEWCONNECT:NSTUS$9.65MUS$9.24Mn/a38.8×n/a3.2×−413.6%0.0×n/a
VVT Med Inc. · TSXV:VVTMUS$8.99MUS$8.99Mn/a93.6×n/an/an/an/a1.16
SpineGuard · EURONEXT:ALSGDUS$8.88MUS$9.65Mn/a2.3×n/a1.8×−55.0%0.3×n/a
Pulsenmore Ltd. · TASE:PLSMUS$8.71MUS$2.27Mn/a0.2×n/a0.3×−39.6%0.0×n/a
Conavi Medical Corp. · TSXV:CNVIUS$8.66MUS$8.89Mn/a15.1×n/an/an/an/a0.36
Allmed Solutions Ltd. · TASE:ALMDUS$8.42MUS$1.41Mn/an/an/a1.4×n/a0.0×n/a
Median of the othersUS$9.32MUS$9.11M8.6×1.6×−234.3%0.0×0.14

Financials

Annual, in TWD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue499.7M451.1M470.2M463.5M480.3M477.6M459.3M
Cost of revenue412.7M354.8M354.5M356.0M359.6M342.8M348.1M
Gross profit87.0M96.3M115.7M107.4M120.7M134.8M111.3M
Research and development34.5M33.4M33.2M30.9M32.3M30.4M30.9M
Selling, general and administrative59.0M41.8M42.5M40.6M37.9M41.3M
Operating income-6.50M3.51M24.9M32.2M26.9M43.6M27.7M
Depreciation and amortization15.4M14.6M15.5M17.3M18.6M17.8M15.7M
EBITDA8.88M18.1M40.4M49.5M45.5M61.5M43.4M
Interest expense1.90M2.05M2.13M2.13M2.18M2.29M2.53M
Income before tax-9.67M17.8M26.5M27.5M23.5M40.1M24.0M
Income tax499.0K5.47M2.10M4.88M8.37M5.57M
Net income-7.87M17.3M21.0M25.4M18.6M31.7M18.4M
Earnings per share, basic-0.330.730.881.060.781.330.77

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents123.1M128.9M195.3M178.7M203.4M221.9M175.8M
Receivables150.4M153.6M92.1M78.8M101.2M80.5M105.9M
Inventory73.2M81.1M72.7M86.4M81.6M49.3M47.3M
Current assets355.5M368.0M366.3M347.8M393.1M355.3M333.0M
Total assets533.2M541.9M543.2M527.8M577.5M547.0M534.6M
Accounts payable72.7M80.6M74.5M58.3M81.4M56.6M62.5M
Current liabilities154.6M129.8M125.0M103.3M157.2M111.3M108.7M
Long-term debt7.76M10.4M13.0M15.5M18.0M
Total debt110.1M115.8M121.4M126.5M131.9M28.4M
Total liabilities252.1M237.3M237.1M219.4M278.2M237.8M240.5M
Shareholders' equity281.1M304.6M306.0M308.4M299.3M309.2M294.1M
Shares outstanding23.8M23.9M23.9M23.9M23.9M23.9M23.9M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations603.0K-32.3M55.2M5.00M32.1M79.9M21.8M
Capital spending-24.0M-14.4M-9.48M-15.0M-12.1M-6.98M-15.2M
Free cash flow-23.4M-46.7M45.7M-9.96M19.9M72.9M6.69M
Cash from financing-24.7M-28.9M-22.6M-34.0M-22.0M-21.8M
Dividends paid-15.9M-19.0M-23.3M-16.7M-28.6M-16.7M-16.7M
Change in cash-5.86M-66.3M16.6M-24.8M-18.5M46.1M-19.0M

Open Financials

Cap table

Built by 6ix from EPS Bio Technology Corp.’s releases

Common shares
23,800,000
Fully diluted
23,800,000

Fully diluted

LineShares
Common shares23,800,000

Share count over time

CountShares
Nov 22, 202623,800,000

Open Cap table

Shareholders

HolderSharesOf the companyAs of
証吉投資有限公司2.78M11.7%Oct 31, 2026
郭鳳琳2.27M9.5%Oct 31, 2026
劉連福1.9M8.0%Oct 31, 2026
游逸帆840K3.5%Oct 31, 2026
郭柏雄700K2.9%Oct 31, 2026
張宏哲653K2.7%Oct 31, 2026
林志衡216K0.91%Oct 31, 2026
羅慶年136K0.57%Oct 31, 2026
卓振輝90,0000.38%Oct 31, 2026
林垂津1,000<0.01%Oct 31, 2026
All 17 holders
HolderSharesOf the companyAs of
黃柏豫00.00%Oct 31, 2026
吳鼎鈞00.00%Oct 31, 2026
鍾欣妤00.00%Oct 31, 2026
羅志鵬00.00%Oct 31, 2026
黃志泰00.00%Oct 31, 2026
郭鳳琳Nov 21, 2026
証吉投資有限公司Nov 21, 2026

Open Shareholders

Log in to ask 6ix AI your own questions about EPS Bio Technology Corp.